Skip to main content
. 2024 Apr 17;6(3):fcae141. doi: 10.1093/braincomms/fcae141

Table 3.

Aβ-peptide molecular signatures between MSA cases with Aβ-predominant ADNC and Alzheimer’s disease cases

MSA 1 MSA 2 MSA 3 MSA 4 AD1 AD2 AD3 AD4 P-value
Thal Aβ phase 5 5 5 5 4 5 5 5 n.s.
Braak NFT stage II I II I–II VI VI VI VI <0.001
CERAD 2 2 2 2 3 3 3 3 <0.01
Aβ immunoreactivity
Temporal cortex
Pan-Aβ (6F3D)
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 2 2 2 2 4 3 3 3 <0.05
40
  Diffuse plaque 3 2 4 3 3 4 4 3 n.s.
  Cored plaque 2 0 1 1 3 3 3 3 <0.05
42
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 2 2 2 2 4 4 3 3 <0.05
43
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 2 1 2 2 4 4 3 3 <0.05
Np3E
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 2 2 2 2 4 3 3 3 <0.05
pSer8
  Diffuse plaque 3 3 3 3 4 4 3 2 n.s.
  Cored plaque 2 1 2 1 3 2 2 2 n.s.
Striatum
Pan-Aβ (6F3D)
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 0 0 1 0 2 3 2 1 <0.05
40
  Diffuse plaque 0 0 1 0 2 3 3 2 <0.05
  Cored plaque 0 0 0 0 2 3 2 0 <0.05
42
  Diffuse plaque 4 4 4 4 4 4 4 4 n.s.
  Cored plaque 0 0 1 0 2 3 2 1 <0.05
43
  Diffuse plaque 3 3 3 3 4 4 4 4 <0.01
  Cored plaque 0 0 0 0 2 3 2 0 <0.05
Np3E
  Diffuse plaque 4 4 4 4 4 3 4 4 n.s.
  Cored plaque 0 0 0 0 2 3 2 1 <0.05
pSer8
  Diffuse plaque 3 2 3 1 3 3 4 1 n.s.
  Cored plaque 0 0 1 0 2 3 0 0 n.s.

Mann–Whitney U test is applied for statistics. The values highlighted in bold indicate statistical significance.

Np3E, pyroglutamate Aβ at the third glutamic acid; AβpSer8, phosphorylated-Aβ at the eighth serine; n.s., not significant.